FDA OK's Medtronic abdominal stent
Last Modified: Wednesday, April 16, 2008 at 11:51 a.m.
Medtronic Inc., which develops vascular technology in Santa Rosa, said Wednesday that U.S. drug regulators have approved its new device for treating abdominal aortic aneurysms, which kill 15,000 people in the United States each year.
The Talent Abdominal Stent Graft on the CoilTrac Delivery System is designed for 20 percent of patients who can’t be treated with existing stent graft systems, Medtronic officials said.
The stent graft was developed in Santa Rosa and is made at a Medtronic facility in Tijuana, Mexico. It is loaded on the delivery system and packaged in Santa Rosa, said Medtronic spokesman Joe McGrath.
The Talent device has been available in Europe for several years. The U.S. Food and Drug Administration approved it for the U.S. market on Tuesday.
An abdominal aortic aneurysm is a bulge or weakening of the body’s main artery that can rupture, causing internal bleeding and death.
Stent grafts are tiny metal-and-fabric devices that are delivered through an artery and placed at the site of the aneurysm. They create a new path for blood to flow, reducing pressure on the aneurysm.
Medtronic has about 1,200 employees in Santa Rosa.
All rights reserved. This copyrighted material may not be re-published without permission. Links are encouraged.
Next Article in Business-Home
-
Toyota to replace 4M gas pedals that could jam
WASHINGTON — Toyota Motor Corp. said Wednesday it will replace accelerator pedals on about 4 million recalled vehicles in the United States because the pedals can get stuck in the floor mats.
As a temporary step, Toyota will have dealers...

Add a Comment
Only moderator-approved comments are shown on this page. To see all comments, please visit the forum. We at PressDemocrat.com created these forums as a place where our community can exchange ideas on news issues and express their thoughts. Please be courteous and respectful. Avoid expletives, false statements, veiled or overt threats and personal attacks. Stay on topic. (View full Terms of Service.)Post a comment | View all comments on this topic.